Antimicrobial-resistant Shigella infections from Iran: An overlooked problem?

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1128-1133

  Tajbakhsh, Mercedeh ^a   García Migura, Lourdes ^b,c   Rahbar, Mohammad ^d   Svendsen, Christina Aaby ^e   Mohammadzadeh, Mona ^f   Zali, Mohammad Reza ^a   Aarestrup, Frank M ^e   Hendriksen, Rene S ^e  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c IRTA   (Spain)

^d Iranian Reference Health Laboratory   (Iran)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f MILAD HOSPITAL   (Iran)

Author keywords

AmpC; Antimicrobial resistance; ESBLs; PFGE; PMQR

Indexed keywords

AMOCARZINE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; APRAMYCIN; BETA LACTAMASE AMPC; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTIOFUR; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; FLORFENICOL; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; NEOMYCIN; QUINOLONE; SPECTINOMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; IRAN; MALE; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; PLASMIDS; QUINOLONES; SHIGELLA; YOUNG ADULT;

EID: 84859570167     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks023     Document Type: Article

References (38)

1. Kotloff KL, Winickoff JP, Ivanoff B et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77: 651-66.
2. Ranjbar R, Soltan Dallal MM, Talebi M et al. Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran. J Health Popul Nutr 2008; 26: 426-30.
3. Jafari F, Garcia-Gil LJ, Salmanzadeh-Ahrabi S et al. Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children's hospitals. J Infect 2009; 58: 21-7.
4. Bennish ML, Wojtyniak BJ. Mortality due to shigellosis: community and hospital data. Rev Infect Dis 1991; 13: 245-51.
5. Nikkah J, Mehr-Movahead A. Antibiotic resistance among Shigella species isolated in Tehran, Iran. Ann Trop Med Parasitol 1988; 82: 481-3.
6. MoezArdalan K, Zali MR, Dallal MM et al. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Karaj, Tehran, Iran. J Health Popul Nutr 2003; 21: 96-102.
7. Niyogi SK. Shigellosis. J Microbiol 2005; 43: 133-43.
8. Sabra AH, Araj GF, Kattar MM et al. Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon. J Infect Dev Ctries 2009; 3: 300-5.
9. Vasilev V, Japheth R, Yishai R et al. Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000-2004. Eur J Clin Microbiol Infect Dis 2007; 26: 189-94.
10. Xiong Z, Li T, Xu Y et al. Detection of CTX-M-14 extended-spectrum β-lactamase in Shigella sonnei isolates from China. J Infect 2007; 55: 125-8.
11. Zhang R, Zhou HW, Cai JC et al. Serotypes and extended-spectrum β-lactamase types of clinical isolates of Shigella spp. from the Zhejiang province of China. Diagn Microbiol Infect Dis 2011; 69: 98-104.
12. Acikgoz ZC, Koseoglu EO, Kocagoz S. CTX-M-3 type β-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases. Jpn J Infect Dis 2008; 61: 135-7.
13. Acikgoz ZC, Gulay Z, Bicmen M et al. CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 2003; 35: 503-5.
14. Hong SJ, Lee CH, Wang JH et al. [Clinical characteristics of extended-spectrum β-lactamase producing Shigella sonnei infection outbreaked in Chungju area.] Korean J Lab Med 2006; 26: 168-73.
15. Rapoport M, Monzani V, Pasteran F et al. CMY-2-type plasmid-mediated AmpC β-lactamase finally emerging in Argentina. Int J Antimicrob Agents 2008; 31: 385-7.
16. Hata M, Suzuki M, Matsumoto M et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005; 49: 801-3.
17. Folster JP, Pecic G, Bowen A et al. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother 2011; 55: 1758-60.
18. Pu XY, Pan JC, Wang HQ et al. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother 2009; 63: 917-20.
19. Niyogi SK. Increasing antimicrobial resistance-an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 2007; 13: 1141-3.
20. Bopp CA, Brenner FW, Fields PI, et al. Escherichia, Shigella, and Salmonella. In: Murray PR, Baron EJ, Jorgensen JH, et al., eds. Manual of Clinical Microbiology. 8th edn. Washington, DC: ASM Press, 2003; 654-71.
21. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M07-A7. CLSI, Wayne, PA, USA, 2006.
22. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals-Third Edition: Approved Standard M31-A3. CLSI, Wayne, PA, USA, 2008.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
24. Hasman H, Mevius D, Veldman K et al. β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother 2005; 56: 115-21.
25. Hendriksen RS, Mikoleit M, Kornschober C et al. Emergence of multidrug-resistant Salmonella Concord infections in Europe and the United States in children adopted from Ethiopia, 2003-2007. Pediatr Infect Dis J 2009; 28: 814-8.
26. Cavaco LM, Hasman H, Xia S et al. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009; 53: 603-8.
27. Périchon B, Courvalin P, Galimand M. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother 2007; 51: 2464-9.
28. Ribot EM, Fair MA, Gautom R et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006; 3: 59-67.
29. Huang IF, Chiu CH, Wang MH et al. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC β-lactamase resistance in S. sonnei. J Clin Microbiol 2005; 43: 2608-12.
30. Livermore DM, Mushtaq S, Nguyen T et al. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae. Int J Antimicrob Agents 2011; 37: 405-9.
31. Hamidian M, Tajbakhsh M, Walther-Rasmussen J et al. Emergence of extended-spectrum β-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis 2009; 62: 368-71.
32. Ashtiani MT, Monajemzadeh M, Kashi L. Trends in antimicrobial resistance of fecal Shigella and Salmonella isolates in Tehran, Iran. Indian J Pathol Microbiol 2009; 52: 52-5.
33. Collignon P, Powers JH, Chiller TM et al. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 2009; 49: 132-41.
34. Aarestrup FM. Monitoring of antimicrobial resistance among food animals: principles and limitations. J Vet Med B Infect Dis Vet Public Health 2004; 51: 380-8.
35. Bager F, Aarestrup FM, Jensen NE et al. Design of a system for monitoring antimicrobial resistance in pathogenic, zoonotic and indicator bacteria from food animals. Acta Vet Scand Suppl 1999; 92: 77-86.
36. Vrints M, Mairiaux E, Van Meerveene E et al. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol 2009; 47: 1379-85.
37. Ranjbar R, Aleo A, Giammanco GM et al. Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002-2003. BMC Infect Dis 2007; 22: 62.
38. Xia S, Xu B, Huang L et al. Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. J Clin Microbiol 2011; 49: 232-42.